Method of calibrating of an analyte-measurement device, and associated methods, devices and systems

• US 8,116,840 B2
• Filed: 10/30/2007
• Issued: 02/14/2012
• Est. Priority Date: 10/31/2003
• Status: Active Grant

• Current Assignee: Abbott Diabetes Care Incorporated (Abbott Laboratories)
• Original Assignee: Abbott Diabetes Care Incorporated (Abbott Laboratories)
• Inventors: Feldman, Benjamin J., McGarraugh, Geoffrey V.
• Primary Examiner(s): Natnithithadha, Navin
• Application Number:
  US11/929,149
• Publication Number:
  US 20080081969A1
• Time in Patent Office: 1,568 Days
• Field of Search: 600/300, 600/309, 600345-366, 422/68.1, 422/82.01, 204/403.01
• US Class Current: 600/345
• CPC Class Codes: A61B 5/0004 characterised by the type of physiological signal transmitted
• CPC Class Codes: A61B 5/0024 for multiple sensor units attached to the patient, e.g. using a body or personal area network
• CPC Class Codes: A61B 5/14532 for measuring glucose, e.g. by tissue impedance measurement
• CPC Class Codes: A61B 5/1486 using enzyme electrodes, e.g. with immobilised oxidase
• CPC Class Codes: A61B 5/14865 invasive, e.g. introduced into the body by a catheter or needle or using implanted sensors
• CPC Class Codes: A61B 5/1495 Calibrating or testing of in-vivo probes
• CPC Class Codes: A61B 5/6898 Portable consumer electronic devices, e.g. music players, telephones, tablet computers
• CPC Class Codes: A61B 5/7246 using correlation, e.g. template matching or determination of similarity
• CPC Class Codes: A61B 5/742 using visual displays A61B5/339 takes precedence
• CPC Class Codes: A61B 5/746 Alarms related to a physiological condition, e.g. details of setting alarm thresholds or avoiding false alarms alarms per se G08B
• CPC Class Codes: A61B 5/7475 User input or interface means, e.g. keyboard, pointing device, joystick

Abstract

The invention relates to a method for calibrating an analyte-measurement device that is used to evaluate a concentration of analyte in bodily fluid at or from a measurement site in a body. The method involves measuring a concentration, or calibration concentration, of an analyte in blood from an “off-finger” calibration site, and calibrating the analyte-measurement device based on that calibration concentration. The invention also relates to a device, system, or kit for measuring a concentration of an analyte in a body, which employs a calibration device for adjusting analyte concentration measured in bodily fluid based on an analyte concentration measured in blood from an “off-finger” calibration site.

Claims

1. An in vivo analyte sensor calibration system, comprising:

an in vivo analyte sensor, at least a portion of the sensor subcutaneously positioned to generate one or more signals;

a calibration sensor configured to be placed in contact with a blood sample from an off-finger calibration site to provide a calibration measurement; and

a calibration device in signal communication with one or more of the in vivo analyte sensor or the calibration sensor to calibrate the in vivo analyte sensor by determining whether a quality of the calibration measurement is suitable for calibration, and converting the one or more signals from the in vivo analyte sensor into a corresponding one or more analyte concentration values using the calibration measurement if the quality of the calibration measurement is determined to be suitable;

wherein the calibration device is configured to determine a temperature compensated analyte concentration value based at least in part on the one or more analyte concentration values and a temperature compensation factor;

wherein the calibration device is further configured to determine a lag compensated analyte concentration value by applying a lag factor to a change in the temperature compensated analyte value over a time period between two acceptable calibration points divided by the time period between the two acceptable calibration points added to the temperature compensated analyte value; and

wherein the two acceptable calibration points is deemed acceptable based on at least one evaluation standard being met.

2. The system of claim 1, wherein the calibration device is configured to evaluate whether the calibration measurement is within a predetermined range of an analyte concentration to determine whether the quality of the calibration measurement is suitable for calibration.

3. The system of claim 2, wherein the predetermined range comprises about 60 mg/dL to about 350 mg/dL.

4. The system of claim 1, wherein the calibration site is an arm.

5. The system of claim 1, wherein the calibration site is an abdomen.

6. The system of claim 1, wherein the blood sample for the calibration measurement is less than about 1 microliter.

7. The system of claim 1, wherein the blood sample for the calibration measurement is less than about 0.5 microliters.

8. The system of claim 1, wherein the blood sample for the calibration measurement is less than about 0.2 microliters.

9. The system of claim 1, wherein the calibration device is configured to determine a sensitivity based on the calibration measurement when the calibration measurement is determined to be suitable.

10. The system of claim 9 wherein the calibration device is configured to calibrate the in vivo analyte sensor based on the determined sensitivity.

11. The system of claim 9 wherein the determined sensitivity includes an unweighted sensitivity.

12. The system of claim 9 wherein the determined sensitivity includes a weighted sensitivity.

13. The system of claim 9 wherein the calibration device determines an adjusted weighing factor based on a raw weighing factor and/or a sensitivity weighing factor, and associated with calibration measurement.

14. The system of claim 1, wherein the calibration device is configured to evaluate the quality of the one or more signals.

15. The system of claim 14, wherein the quality of the generated one or more signals is based on evaluating a rate of change of the one or more signals from the in vivo analyte sensor.

16. The system of claim 14, wherein the calibration device is configured to determine a sensitivity based on the evaluated quality of the one or more signals from the in vivo analyte sensor.

17. The system of claim 1, wherein the calibration sensor is an in vitro sensor.

18. The system of claim 1, wherein the calibration sensor is an in vivo calibration sensor.

19. The system of claim 1, wherein the in vivo analyte sensor is a transcutaneous sensor.

20. The system of claim 1, wherein the in vivo analyte sensor is a glucose sensor.

21. The system of claim 1, wherein the calibration device rejects the calibration measurement if the quality of the calibration measurement is determined to be unacceptable.

22. The system of claim 21 wherein the calibration device evaluates a subsequent calibration measurement to determine whether the quality of the subsequent calibration measurement is determined to be suitable.

23. The system of claim 22 wherein the calibration device converts the one or more signals from the in vivo analyte sensor into the corresponding one or more analyte concentration values using the subsequent calibration measurement.

24. The system of claim 1 wherein applying the lag factor to the change in the temperature compensated analyte value over the time period between the two acceptable calibration points includes multiplying the lag factor with the change in the temperature compensated analyte value over the time period between the two acceptable calibration points.

25. The system of claim 1 wherein the two acceptable calibration points include two consecutive calibration points.

26. The system of claim 1 wherein the calibration device is configured to determine the temperature compensated analyte concentration value by multiplying the analyte concentration value by the temperature compensation factor raised to a power equal to the temperature at the time associated with the calibration measurement minus the temperature at the time associated with the generated one or more signals from the in vivo analyte sensor.